Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.

The agency approved the first CGM for over-the-counter use in March. Stelo, by Dexcom, was approved for anyone 18 and older ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Dexcom has rounded up its celebrity spokespeople for World Diabetes Day, putting singer Nick Jonas at the center of a ...

However, there remain good reasons to invest in the company. Let's first review what DexCom does. The company is a leader in ...

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

The U.S. spends $413 billion dollars each year on diabetes-related care, meaning that diabetic patients now account for one of every four healthcare dollars spent in the country. The first step in ...

SAN DIEGO, September 18, 2024--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of the third ...

This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging ...

DexCom, Inc. (NASDAQ:DXCM) is a medical device company, which focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the US and internationally.

DexCom, Inc. (NASDAQ:DXCM) is a medical device company that develops and commercializes continuous glucose monitoring (CGM) ...